Other Undergraduate 355 words

Hypocholesterolemic Agents: Statins, Niacin, and Cholesterol

~2 min read

Abstract

This discussion response engages with a peer's post on hypocholesterolemic agents, expanding on the classification of lipoproteins and the mechanisms by which cholesterol-lowering drugs operate. The paper reviews how low-density lipoprotein (LDL) is considered "bad" cholesterol due to its association with increased stroke and heart disease risk, while high-density lipoprotein (HDL) helps remove excess cholesterol. It examines how statins lower plasma LDL by blocking the mevalonate pathway and inhibiting HMG-CoA conversion, and how niacin reduces triglyceride synthesis while raising HDL — but with a risk of liver toxicity through its crystalline form, nicotinic acid.

📝 How to Write This Type of Paper Writing guide — click to expand

▼

What makes this paper effective

The response directly engages with a peer's claims, adding detail and nuance rather than simply restating what was said — a hallmark of effective academic discussion board writing.
Specific mechanisms (the mevalonate pathway, HMG-CoA inhibition) are cited with appropriate sources, grounding the analysis in pharmacological evidence.
The paper honestly acknowledges prior gaps in the student's own knowledge, lending authenticity and intellectual honesty to the discussion.

Key academic technique demonstrated

The paper demonstrates source integration in a peer-response format: the student attributes claims clearly (CDC, Ward et al., Djadjo), uses in-text citations consistently, and distinguishes between what the peer introduced and what the student independently researched — showing how to build on rather than merely summarize a classmate's post.

Structure breakdown

The response is organized into two substantive paragraphs. The first establishes background on lipoprotein classification and cholesterol types, contextualizing the peer's post. The second paragraph focuses on the pharmacological mechanisms of the two drugs highlighted by the peer — statins and niacin — adding detail on their modes of action and side effects. A properly formatted APA reference list closes the response.

Introduction to Lipoproteins and Cholesterol Classification

Lipoproteins have varying densities and are thus classified as high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and chylomicrons. According to the Centers for Disease Control and Prevention (CDC), most of the cholesterol in the body is low-density lipoprotein. This cholesterol is termed "bad" cholesterol because when its levels are high, the risk of stroke and heart disease rises. As Katie highlighted, high-density lipoproteins are present in smaller amounts. According to the CDC (2020), HDL absorbs excess cholesterol and transports it to the liver, where it is flushed out of the body. When cholesterol levels are high, hypocholesterolemic drugs are prescribed to help lower them.

Statins: Mechanism of Action in Lowering LDL

Katie opted to focus on statins and niacin as examples of drugs that can be prescribed to achieve this effect. One aspect of statins that was not previously clear is their mode of action. According to Ward et al. (2019), statins are a first-choice drug in lowering plasma LDL. The authors further explain that statins lower LDL by blocking the mevalonate pathway, which is the active site involved in cholesterol synthesis. When this pathway is blocked, HMG-CoA is prevented from converting to mevalonic acid. As a result, hepatic cholesterol synthesis is reduced, leading to an increase in cell-surface expression of LDL receptors, which facilitates the removal of LDL from circulation (Ward et al., 2019).

2 Locked Sections · 115 words remaining

61% of this paper shown

Niacin as a Cholesterol-Lowering Agent and Hepatotoxicity Risk · 75 words

"Niacin's lipid effects and liver toxicity risk"

References · 40 words

"APA citations for CDC, Djadjo, and Ward et al."

130,000+ paper examplesAI writing assistantCitation generatorCancel anytime

Key Concepts in This Paper

LDL Cholesterol HDL Cholesterol Statins Niacin Mevalonate Pathway HMG-CoA Inhibition Liver Toxicity Triglyceride Synthesis Lipoprotein Classification Hypocholesterolemic Drugs